Kura Oncology Stock Future Price Prediction


USD 13.07  0.59  4.32%   

Kura Oncology stock price prediction is an act of determining the future value of Kura Oncology shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Kura Oncology's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Kura Oncology and does not consider all of the tangible or intangible factors available from Kura Oncology's fundamental data. We analyze noise-free headlines and recent hype associated with Kura Oncology, which may create opportunities for some arbitrage if properly timed.
Please see Kura Oncology Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Kura Oncology based on different types of headlines from major news networks to social media. The Kura Oncology stock price prediction module provides an analysis of price elasticity to changes in media outlook on Kura Oncology over a specific investment horizon.Using Kura Oncology hype-based prediction, you can estimate the value of Kura Oncology from the perspective of Kura Oncology response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Kura Oncology using Kura Oncology's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Kura Oncology using crowd psychology based on the activity and movement of Kura Oncology's stock price.

Kura Oncology Implied Volatility

Kura Oncology's implied volatility exposes the market's sentiment of Kura Oncology stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Kura Oncology's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Kura Oncology stock will not fluctuate a lot when Kura Oncology's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Kura Oncology. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Kura Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Kura Oncology because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Kura Oncology after-hype prediction price

  $ 13.73  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Kura Oncology contract

Based on the Rule 16, the options market is currently suggesting that Kura Oncology will have an average daily up or down price movement of about 9.89% per day over the life of the 2022-10-21 option contract. With Kura Oncology trading at $13.07, that is roughly $1.29. If you think that the market is fully incorporating Kura Oncology's daily price movement you should consider acquiring Kura Oncology options at the current volatility level of 158.2%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Kura Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Kura Oncology in the context of predictive analytics.
LowReal ValueHigh
5 Analysts
LowTarget PriceHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kura Oncology. Your research has to be compared to or analyzed against Kura Oncology's peers to derive any actionable benefits. When done correctly, Kura Oncology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Kura Oncology.

Kura Oncology After-Hype Price Prediction Density Analysis

As far as predicting the price of Kura Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kura Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Kura Oncology, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Kura Oncology Estimiated After-Hype Price Volatility

In the context of predicting Kura Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kura Oncology's historical news coverage. Kura Oncology's after-hype downside and upside margins for the prediction period are 10.11 and 17.35, respectively. We have considered Kura Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 13.07
After-hype Price
Kura Oncology is not too volatile asset. Analysis and calculation of next after-hype price of Kura Oncology is based on 3 months time horizon.

Kura Oncology Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Kura Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kura Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kura Oncology, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.52  3.62  0.07   0.16  4 Events / Month4 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Kura Oncology Hype Timeline

Kura Oncology is now traded for 13.07. The entity has historical hype elasticity of 0.07 and average elasticity to hype of competition of 0.16. Kura Oncology is projected to increase in value after the next headline with the price projected to jump to 13.73 or above. The average volatility of media hype impact on the company stock price is over 100%. The price jump on the next news is forecasted to be 0.51% whereas the daily expected return is now at -0.52%. The volatility of related hype on Kura Oncology is about 1160.26% with expected price after next announcement by competition of 13.23. Net Loss for the year was (132.22 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next projected press release will be in about 4 days.
Please see Kura Oncology Basic Forecasting Models to cross-verify your projections.

Kura Oncology Related Hype Analysis

Having access to credible news sources related to Kura Oncology's direct competition is more important than ever and may enhance your ability to predict Kura Oncology's future price movements. Getting to know how Kura Oncology rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kura Oncology may potentially react to the hype associated with one of its peers.

Kura Oncology Additional Predictive Modules

Most predictive techniques to examine Kura Oncology price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kura Oncology using various technical indicators. When you analyze Kura Oncology charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Kura Oncology Predictive Indicators

The successful prediction of Kura Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kura Oncology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kura Oncology based on analysis of Kura Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kura Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kura Oncology's related companies.

Story Coverage note for Kura Oncology

The number of cover stories for Kura Oncology depends on current market conditions and Kura Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kura Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kura Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Kura Oncology Short Properties

Kura Oncology's future price predictability will typically decrease when Kura Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kura Oncology often depends not only on the future outlook of the potential Kura Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kura Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out7.97%
Short Percent Of Float8.13%
Float Shares41.79M
Shares Short Prior Month4.85M
Average Daily Volume Last 10 Day1.08M
Average Daily Volume In Three Month844.52k
Date Short Interest15th of July 2022
Please see Kura Oncology Basic Forecasting Models to cross-verify your projections. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for analysis

When running Kura Oncology price analysis, check to measure Kura Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kura Oncology is operating at the current time. Most of Kura Oncology's value examination focuses on studying past and present price action to predict the probability of Kura Oncology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kura Oncology's price. Additionally, you may evaluate how the addition of Kura Oncology to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is Kura Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kura Oncology. If investors know Kura Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kura Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kura Oncology is measured differently than its book value, which is the value of Kura Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Kura Oncology's value that differs from its market value or its book value, called intrinsic value, which is Kura Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kura Oncology's market value can be influenced by many factors that don't directly affect Kura Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kura Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine Kura Oncology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kura Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.